SEC Form D · filed August 15, 2022
Shuttle Pharmaceuticals Holdings, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Milton Brown · Rockville, MDExec · DirectorChris Senanayake · Rockville, MDDirectorWilliam Adkins · Rockville, MDDirectorPeter Dritschillo · Rockville, MDExecSteven Richards · Rockville, MDDirectorTyvin Rich · Rockville, MDExecMira Jung · Rockville, MDExecJoshua Schafer · Rockville, MDDirectorMichael Vander Hoek · Rockville, MDExecAnatoly Dritschilo · Rockville, MDExec · DirectorPeter Oberle · Denver, COExecBenjamin R. Clouse · Leawood, KSExecAmy R. Fauss · Leawood, KSDirectorJames W. Kuykendall · Leawood, KSExecAZM Asset Management, LP · Houston, TXDirectorAmy C. Abrams · Leawood, KSExec · DirectorSteven W. Caple · Leawood, KSDirectorRobert Schultz · Denver, CODirectorBen Deda · Denver, COExecGeorge E. Hansen Iii · Leawood, KSExec · DirectorLisa M. Longino · Jersey City, NJDirectorGulshan R. Ramgoolam · Ebene, O4ExecTooram R. Gopall · Ebene, O4ExecMark R. Shenkman · New York, NYDirectorDan J. Cohrs · Vancouver, British Columbia, CanadaDirectorDavid S. Urquhart · Woollahra, Channel IslandsExec · DirectorArthur D. Hyde, Iv · West Palm Beach, FLExec · DirectorAdam Rodman · West Palm Beach, FLExecJun Li · PETALUMA, CAExecMark Weinberg · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗